Mapinastine

Drug Profile

Mapinastine

Alternative Names: E 4707; E 4716

Latest Information Update: 06 Nov 1996

Price : $50

At a glance

  • Originator Esteve
  • Class Antiallergics; Antihistamines; Small molecules
  • Mechanism of Action Histamine release inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Respiratory tract disorders

Most Recent Events

  • 06 Nov 1996 Discontinued-II for Respiratory tract disorders in Spain (Unknown route)
  • 18 Jan 1996 Phase-II clinical trials for Respiratory tract disorders in Spain (Unknown route)
  • 18 Aug 1995 E 4716 is now called mapinastine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top